PRISMAP final event

The final PRISMAP public event will take place on 18–19 November 2025 in Warsaw and online.

On this occasion, we will report on the highlights of PRISMAP user projects and our own research activities. We will also discuss the lessons learnt from this research infrastructure project, the conclusions and our way forward.

Moreover, there will be a poster session for which all participants are kindly invited to bring a poster.

Agenda

Day 1 — 18 November 2025

Date

13.00	Registration
13.30	PRISMAP in a nutshell	Thierry Stora (CERN)
14.00	Welcome to the Heavy Ion Laboratory (HIL)	Dr Jaroslaw Choiński, deputy director of HIL
14.30	The European Radioisotope Valley Initiative Roadmap - a plan to secure the long-term supply of medical radioisotopes in Europe	ERVI representative, TBC
PRISMAP final results
15.00	Strategic engagement with emerging infrastructures	Lucia-Ana Popescu (SCK CEN)
15.20	Development and optimisation of targets, ion sources, and enrichment techniques for medical radionuclide production	Mattia Manzolaro (INFN)
15.50	Short break
16.00	Results and lessons learned from 4 years of transnational transport of novel radionuclides	Mikael Jensen (DTU)
16.20	Translational data generation	Seán Collins (NPL)
17.00	Medically relevant radiolanthanides: Exploring today's breakthroughs and tomorrow's possibilities	Zeynep Talip (PSI)
PRISMAP services
17.20	PRISMAP services for radionuclide production and their biomedical application	Ulli Köster (ILL)
17.40	PRISMAP services seen from the perspective of the user selection panel	Conny Hoehr (TRIUMF)
18.00	Poster session - Networking and drinks
19.00	End of the event
19.30	Dinner

Day 2 — 19 Novenber 2025

Date

8.30	Reception
Regulatory Requirements
9.00	Experience with novel radionuclides in radiopharmacy	Serge Lyashchenko, (MSKCC, New York, USA)
9.30	A bumpy road to standardize and harmonize the regulatory requirements for radiopharmaceutical production involving novel radionuclides	Clemens Decristoforo (Medical University Innsbruck)
10.00	Open discussion	Clemens Decristoforo
10.30	Short break with poster session
Industrial Collaboration
11.00	10 years of experience in radiopharmacy of the Synektik S.A. Research and Development Centre	Łukasz Steczek, Synektik Pharma Sp. z o.o.
11.30	New Voxel Innovation Campus – challenges and perspectives for Polish radiopharmaceutical community	Marek Pilch-Kowalczyk, Technology Advisor, Voxel SA
12.00	NCBJ Radioisotope Centre POLATOM in the logistics of radioactive goods	Tomasz Chwaliński, Head of Air Transport Section, NCBJ POLATOM
12.30	Polysaccharide nanoparticles as drug and isotope carrier in cancer therapy	Tomasz Ciach, Warsaw University of Technology
13.00	Lunch
Results from the user projects enabled by PRISMAP
14.30	General overview of theranostics impact in oncology	Jolanta Kunikowska, Warsaw Medical University
15.00	Translational investigations of new PSMA-targetting radiobioconjugates based on theranostic Pb-203 and Pb-212 (tentative)	Marc Pretze, Constantin Mamat, Carmen Waengler (U. Dresden, U. Heidelberg)
15.30	Break
16.00	Manganese-52 for applications on multiple coincidence detection in Positron Emission Tomography	Pawel Moskal (Jagiellonian University in Krakow, Poland) - TBC
16.30	New in-vivo models and new radionuclides for efficient evaluation of targeted radionuclide therapy	Clement Morgat (U. Bordeaux)
17.00	Treatment Efficacy of 161Tb-Labeled GRPR Ligands in Comparison with their 177Lu-Labeled Analog	Thomas Guenther (Stanford University, USA)
17.30	End of day 1